clinical trial · NCT07668414
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Novo Nordisk A/S·phase3·recruiting·n = 650
OverweightObesityZenagamtideSemaglutidePlacebo (matched to semaglutide)Placebo (matched to zenagamtide)
brief summary
The purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treatment with semaglutide.
started
Sep 22, 2026
primary completion
Oct 10, 2028
completion
Oct 10, 2028
last updated
Sep 28, 2026
official title
Efficacy and Safety of Zenagamtide s.c. Once-weekly Compared to Semaglutide s.c. Once-weekly in Participants With Obesity (AMAZE 7)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol